Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers identify starting point for designing drugs that cure clostridium difficile

03.01.2020

Scientists combined multiple advanced molecular imaging techniques to characterize and understand how C. diff toxins work

  • Clostridium Difficile (C. diff) is a virulent health care-associated infection responsible for nearly 13,000 deaths and over $5 billion in health care related costs annually in the U.S.
  • Overuse of antibiotics has helped spread C. diff, one of the most difficult to treat bacterial infections.
  • Researchers from the Advanced Science Research Center at The Graduate Center, CUNY; Maryland School of Medicine; Institute for Bioscience and Botechnology Research; and Merck have characterized the molecular structure of the binary toxin driving some drug-resistant strains of C. diff.
  • The work provides a new target for effective treatment of the most dangerous strains of this life-threatening bacteria.

This atomic illustration shows the newly identified CDTB component of the binary C. diff toxin, which researchers now know attaches to the surface of human cells and injects the CDTA portion of the toxin inside the cell.

Credit: Xingjian Xu and Edwin Pozharski

Usage Restrictions: Can be used in conjunction with this study.

A newly published paper in PNAS details a research breakthrough that provides a promising starting point for scientists to create drugs that can cure C. diff -- a virulent health care-associated infection that causes severe diarrhea, nausea, internal bleeding, and potentially death. The bacteria affects roughly half-a-million Americans and causes nearly 15,000 deaths in the U.S. annually.

Overuse of antibiotics has increasingly put patients in heath care facilities at risk for acquiring C. diff and made some strains of the bacteria particularly hard to treat. But newly discovered information about a type of toxin released by the most dangerous strains of C. diff is providing researchers with a map for developing drugs that can block the toxin and prevent the bacteria from entering human cells.

"The most dangerous strains of C. diff release a binary toxin that first binds to cells and then creates a pore-forming channel that allows the toxin to get inside and do harm," said Amedee de Georges, the study's principal investigator and a professor with the Advanced Science Research Center at The Graduate Center, CUNY's Structural Biology Iniative.

"We were able to combine several increasingly popular biophysical imaging techniques to visualize and characterize every atom of this binary toxin and show us where they are positioned. These details provide a critical and extremely useful starting point for designing drugs that can prevent C. diff infection."

Researchers used a combination of tools -- cryogenic electron microscopy, X-ray crystallography, nuclear magnetic resonance, and small angle X-ray scattering -- to observe and identify the C. diff toxin's structure and mode of action. Researchers believed that it is a binary toxin (meaning it needs two components to function) that might employ a similar method to anthrax toxin to enter cells. Using that as their starting point, they sought to characterize how C. diff toxin is different than anthrax.

"We observed two similar but distinct forms of the C. diff toxin -- one where we see the pore-forming channel and one where it is invisible," said the first author, Xingjian Xu, a Graduate Center, CUNY Ph.D. student and a researcher in de Georges' lab. "This gives us clues as to how to prevent the formation of the channel and stop the bacteria from entering the cell."

Researchers also identified a novel calcium binding site on one of the C. diff toxin's domains. This type of binding structure hasn't been identified on any other similar toxins, suggesting that calcium plays a critical role in regulating the formation and transition C. diff into cells.

The study's findings will guide the design of drugs targeting C. diff infections, and specifically, the more severe C. diff bacteria strains.

###

This research was funded by the National Institutes of Health, National Science Foundation Division of Chemistry, and the U.S. Department of Health and Human Services.

About the Advanced Science Research Center

The Advanced Science Research Center (ASRC) at The Graduate Center, CUNY is a world-leading center of scientific excellence, which elevates scientific research and education at CUNY and beyond through initiatives in five distinctive, but broadly interconnected disciplines: nanoscience, photonics, neuroscience, structural biology, and environmental sciences. The ASRC promotes a collaborative, interdisciplinary research culture where renowned scientists advance their discoveries using state-of-the-art equipment and cutting-edge core facilities.

About The Graduate Center of The City University of New York

The Graduate Center, CUNY is a leader in public graduate education devoted to enhancing the public good through pioneering research, serious learning, and reasoned debate. The Graduate Center offers ambitious students more than 40 doctoral and master's programs of the highest caliber, taught by top faculty from throughout CUNY -- the nation's largest public urban university. Through its nearly 40 centers, institutes, initiatives, and the Advanced Science Research Center, The Graduate Center influences public policy and discourse and shapes innovation. The Graduate Center's extensive public programs make it a home for culture and conversation.

Media Contact

Shawn Rhea
srhea@gc.cuny.edu
212-817-7180

 @asrc_gc

http://asrc.cuny.edu 

Shawn Rhea | EurekAlert!
Further information:
http://dx.doi.org/10.1073/pnas.1919490117

More articles from Life Sciences:

nachricht Life's clockwork: Scientist shows how molecular engines keep us ticking
14.01.2020 | University of North Carolina Health Care

nachricht World Premiere in Zurich: Machine keeps human livers alive for one week outside of the body
14.01.2020 | Universitätsspital Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: World Premiere in Zurich: Machine keeps human livers alive for one week outside of the body

Researchers from the University Hospital Zurich, ETH Zurich, Wyss Zurich and the University of Zurich have developed a machine that repairs injured human livers and keep them alive outside the body for one week. This breakthrough may increase the number of available organs for transplantation saving many lives of patients with severe liver diseases or cancer.

Until now, livers could be stored safely outside the body for only a few hours. With the novel perfusion technology, livers - and even injured livers - can now...

Im Focus: SuperTIGER on its second prowl -- 130,000 feet above Antarctica

A balloon-borne scientific instrument designed to study the origin of cosmic rays is taking its second turn high above the continent of Antarctica three and a half weeks after its launch.

SuperTIGER (Super Trans-Iron Galactic Element Recorder) is designed to measure the rare, heavy elements in cosmic rays that hold clues about their origins...

Im Focus: LZH’s MOMA laser ready for the flight to Mars

One last time on Earth it has been turned on in France in December 2019. The next time the MOMA laser developed by the Laser Zentrum Hannover e.V. (LZH) is going into operation will be on Mars. The ExoMars rover into which the laser is integrated has now successfully passed the thermal vacuum tests at Airbus in Toulouse, France.

For 18 days the ExoMars rover Rosalind Franklin was subjected to thermal vacuum tests at Airbus. There, it had to withstand strong changes in temperature and...

Im Focus: Atacama Desert: A newly discovered biocoenosis of lichens, fungi and algae shapes entire landscapes

The Atacama Desert in Chile is the oldest and most arid desert on earth. Organisms living in this area have adapted to the extreme conditions over thousands of years. A research team led by Dr Patrick Jung has now discovered and investigated a previously unknown biocoenosis of lichens, fungi, cyanobacteria and algae. It colonises tiny stones, so-called grit and its need for water is satisfied by fog and dew. These organisms also decompose the rock on and in which they live. The scientists believe that this is how they have shaped the landscape of the Atacama Desert. Their study was published in the renowned scientific journal "Gebiology".

Many desert areas have large black spots in the sand. These spots are mineral deposits, so-called desert varnish. In the Atacama Desert, which can be compared...

Im Focus: Nano antennas for data transfer

For the first time, physicists from the University of Würzburg have successfully converted electrical signals into photons and radiated them in specific directions using a low-footprint optical antenna that is only 800 nanometres in size.

Directional antennas convert electrical signals to radio waves and emit them in a particular direction, allowing increased performance and reduced...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

„Advanced Battery Power“- Conference, Contributions are welcome!

07.01.2020 | Event News

International Coral Reef Symposium 2020 Holds Photo Competition

19.12.2019 | Event News

The Future of Work

03.12.2019 | Event News

 
Latest News

Scientists in Mainz develop a more sustainable photochemistry

14.01.2020 | Life Sciences

Laserphysics: At the pulse of a light wave

13.01.2020 | Physics and Astronomy

New function for potential tumor suppressor in brain development

13.01.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>